I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Teper, Ariel
68
results:
Search for persons
X
Format
Online (68)
Mediatypes
Articles (Online) (47)
OpenAccess-fulltext (21)
Sorted by: Relevance
Sorted by: Year
?
1
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN pr..:
Chalmers, James D.
;
Burgel, Pierre-Régis
;
Daley, Charles L.
...
ERJ Open Research. 10 (2024) 4 - p. 00151-2024 , 2024
Link:
https://doi.org/10.1183/..
?
2
Benefit−risk assessment of brensocatib for treatment of non..:
Chalmers, James D.
;
Metersky, Mark L.
;
Feliciano, Joseph
...
ERJ Open Research. 9 (2023) 3 - p. 00695-2022 , 2023
Link:
https://doi.org/10.1183/..
?
3
Dipeptidyl peptidase-1 inhibition with brensocatib reduces ..:
Cipolla, David
;
Zhang, Jimin
;
Korkmaz, Brice
...
Respiratory Research. 24 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
4
Safety, Tolerability, and Pharmacokinetic Evaluation of Sin..:
Usansky, Helen
;
Yoon, Esther
;
Teper, Ariel
..
Clinical Pharmacology in Drug Development. 11 (2022) 7 - p. 832-842 , 2022
Link:
https://doi.org/10.1002/..
?
5
Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidy..:
Chalmers, James D.
;
Usansky, Helen
;
Rubino, Christopher M.
...
Clinical Pharmacokinetics. 61 (2022) 10 - p. 1457-1469 , 2022
Link:
https://doi.org/10.1007/..
?
6
Safety, Tolerability, and Pharmacokinetics of Treprostinil ..:
Ismat, Fraz A.
;
Usansky, Helen H.
;
Villa, Raul
..
Advances in Therapy. , 2022
Link:
https://doi.org/10.1007/..
?
7
Impact of exacerbations on lung function, resource utilizat..:
Wisnivesky, Juan
;
Federmann, Emily
;
Eckert, Laurent
...
Journal of Asthma. 60 (2022) 6 - p. 1072-1079 , 2022
Link:
https://doi.org/10.1080/..
?
8
Effect of exacerbation history on clinical response to dupi..:
Corren, Jonathan
;
Katelaris, Constance H.
;
Castro, Mario
...
European Respiratory Journal. 58 (2021) 4 - p. 2004498 , 2021
Link:
https://doi.org/10.1183/..
?
9
Dupilumab efficacy in adolescents with uncontrolled, modera..:
Maspero, Jorge F.
;
FitzGerald, John Mark
;
Pavord, Ian D.
...
Allergy. 76 (2021) 8 - p. 2621-2624 , 2021
Link:
https://doi.org/10.1111/..
?
10
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-..:
Corren, Jonathan
;
Castro, Mario
;
O'Riordan, Thomas
...
The Journal of Allergy and Clinical Immunology: In Practice. 8 (2020) 2 - p. 516-526 , 2020
Link:
https://doi.org/10.1016/..
?
11
Dupilumab Efficacy in Patients Stratified by Baseline Treat..:
Pavord, Ian D
;
Siddiqui, Salman
;
Papi, Alberto
...
Journal of Asthma and Allergy. 13 (2020) - p. 701-711 , 2020
Link:
https://doi.org/10.2147/..
?
12
Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asth..:
Maspero, Jorge F.
;
Katelaris, Constance H.
;
Busse, William W.
...
The Journal of Allergy and Clinical Immunology: In Practice. 8 (2020) 2 - p. 527-539.e9 , 2020
Link:
https://doi.org/10.1016/..
?
13
Dupilumab efficacy and safety in Japanese patients with unc..:
Tohda, Yuji
;
Nakamura, Yoichi
;
Fujisawa, Takao
...
Allergology International. 69 (2020) 4 - p. 578-587 , 2020
Link:
https://doi.org/10.1016/..
?
14
Dupilumab Efficacy in GINA-Defined Difficult-to-Treat Type ..:
Rabe, Klaus
;
FitzGerald, J.
;
Bateman, Eric
...
Journal of Allergy and Clinical Immunology. 145 (2020) 2 - p. AB19 , 2020
Link:
https://doi.org/10.1016/..
?
15
The effect of dupilumab on lung function parameters in pati..:
Rabe, Klaus F.
;
Nair, Parameswaran
;
Maspero, Jorge F.
...
Respiratory Medicine: X. 2 (2020) - p. 100010 , 2020
Link:
https://doi.org/10.1016/..
1-15